Bio-Techne Corp. buy UBS Group AG
Start price
06.11.25
/
50%
€50.50
Target price
06.11.26
€60.82
Performance (%)
-11.37%
Price
13.03.26
€44.60
Summary
This prediction is currently active. The price of Bio-Techne Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.37%. A total of €0.16 was paid as dividends for this prediction. This prediction currently runs until 06.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -10.442% | -10.442% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at UBS Group AG from $65.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat